Hydramacroside B

CAS No.:161161-67-7

TBZ1411
(4S)-1-[(1S,9S,10S)-10-ethenyl-5-oxo-9-[(2S,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,8-dioxabicyclo[4.4.0]dec-6-en-3-yl]-4-hydroxy-8-(4-hydroxyphenyl)octane-2,6-dione;(4S)-1-[(1S,9S,10S)-10-ethenyl-5-oxo-9-[(2S,3R,4R,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,8-dioxabicyclo[4.4;(4aS,5R,6S)-5-ethenyl-3-[(4S)-4-hydroxy-8-(4-hydroxyphenyl)-2,6-dioxooctyl]-1-oxo-4,4a,5,6-tetrahydro-1H,3H-pyrano[3,4-c]pyran-6-yl beta-D-allopyranoside;Hydramacroside B
inquiry
C30H38O13
606.61

Product introduction

Category: Iridoids
Appearance: powder
Purity: 95~98%(HPLC)
Storage conditions: -20°C under seal save, placed in ventilated, dry environment
Application: All our products are for research and lab only. Injecting, eating and other ways are forbidden.
Package: 5mg,10mg ,20mg ,50mg ,100mg,1g, 100g or customized
SMILES: C(C1C2C(C(=O)OC(CC(=O)CC(O)CC(=O)CCC3C=CC(O)=CC=3)C2)=COC1OC1C(O)C(O)C(O)C(CO)O1)=C